繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

人工智能医疗科技公司Carlsmed IPO定价为1亿美元

2025-07-23 13:24

  • Carlsmed (CARL) has priced its initial public offering at $15 per share, offering 6.7 million shares and aiming to raise around $100.5 million in gross proceeds, excluding any underwriters’ option.
  • Shares will trade on Nasdaq under the ticker “CARL” starting July 23, 2025, with the offering expected to close the following day.
  • Underwriters have a 30-day option to buy up to 1.005 million additional shares.
  • Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。